Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy.
about
Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Lenalidomide as second-line th ...... arkers for treatment efficacy.
@en
Lenalidomide as second-line th ...... arkers for treatment efficacy.
@nl
type
label
Lenalidomide as second-line th ...... arkers for treatment efficacy.
@en
Lenalidomide as second-line th ...... arkers for treatment efficacy.
@nl
prefLabel
Lenalidomide as second-line th ...... arkers for treatment efficacy.
@en
Lenalidomide as second-line th ...... arkers for treatment efficacy.
@nl
P2093
P2860
P50
P356
P1476
Lenalidomide as second-line th ...... markers for treatment efficacy
@en
P2093
P2860
P304
P356
10.1111/APT.14270
P407
P577
2017-08-17T00:00:00Z